1. Home
  2. OTLK vs CSAI Comparison

OTLK vs CSAI Comparison

Compare OTLK & CSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • CSAI
  • Stock Information
  • Founded
  • OTLK 2010
  • CSAI N/A
  • Country
  • OTLK United States
  • CSAI
  • Employees
  • OTLK N/A
  • CSAI 18
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • CSAI
  • Sector
  • OTLK Health Care
  • CSAI
  • Exchange
  • OTLK Nasdaq
  • CSAI NYSE
  • Market Cap
  • OTLK 48.3M
  • CSAI 53.1M
  • IPO Year
  • OTLK 2016
  • CSAI N/A
  • Fundamental
  • Price
  • OTLK $1.77
  • CSAI $2.41
  • Analyst Decision
  • OTLK Strong Buy
  • CSAI
  • Analyst Count
  • OTLK 5
  • CSAI 0
  • Target Price
  • OTLK $10.20
  • CSAI N/A
  • AVG Volume (30 Days)
  • OTLK 689.4K
  • CSAI N/A
  • Earning Date
  • OTLK 05-15-2025
  • CSAI N/A
  • Dividend Yield
  • OTLK N/A
  • CSAI N/A
  • EPS Growth
  • OTLK N/A
  • CSAI N/A
  • EPS
  • OTLK 0.83
  • CSAI N/A
  • Revenue
  • OTLK N/A
  • CSAI N/A
  • Revenue This Year
  • OTLK N/A
  • CSAI N/A
  • Revenue Next Year
  • OTLK $288.46
  • CSAI N/A
  • P/E Ratio
  • OTLK $2.12
  • CSAI N/A
  • Revenue Growth
  • OTLK N/A
  • CSAI N/A
  • 52 Week Low
  • OTLK $0.87
  • CSAI N/A
  • 52 Week High
  • OTLK $9.25
  • CSAI N/A
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 57.64
  • CSAI N/A
  • Support Level
  • OTLK $1.55
  • CSAI N/A
  • Resistance Level
  • OTLK $1.90
  • CSAI N/A
  • Average True Range (ATR)
  • OTLK 0.18
  • CSAI 0.00
  • MACD
  • OTLK 0.01
  • CSAI 0.00
  • Stochastic Oscillator
  • OTLK 53.10
  • CSAI 0.00

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About CSAI CLOUDASTRUCTURE INC

Cloudastructure Inc is engaged in cloud-based artificial intelligence (AI) video surveillance and Remote Guarding service built on AI and machine learning platforms. Its products/ services include Cloud Video Surveillance, Remote Guarding, Remote Guards, Cloud Video Recorder (CVR), Cameras and Speakers, Mobile Surveillance Trailer, etc.

Share on Social Networks: